News Kaneka Corporation

Equities

4118

JP3215800008

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-25 am EDT			5-day change	1st Jan Change
3,935 ^JPY	-0.78%		-0.13%	+9.85%

Apr. 22	Sony Corporation Adopts Kaneka Corporation's Foam Molded Product Made from Kaneka Biodegradable Polymer Green Planet as A Cushioning Material for Its Large-Screen Televisions	CI
Apr. 01	Tranche Update on Kaneka Corporation's Equity Buyback Plan announced on February 8, 2024.	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Foam Molded Product made from KANEKA Biodegradable Polymer Green PlanetTM Adopted for Sony’s Large-screen TV Cushioning Material	Apr. 22	BU
Sony Corporation Adopts Kaneka Corporation's Foam Molded Product Made from Kaneka Biodegradable Polymer Green Planet as A Cushioning Material for Its Large-Screen Televisions	Apr. 22	CI
Sony is the Industry's First to Eliminate Polystyrene Foam Packaging for Large TVs	Apr. 18	AQ
Tranche Update on Kaneka Corporation's Equity Buyback Plan announced on February 8, 2024.	Apr. 01	CI
Final dividend	Mar. 27	FA
Kaneka Corporation announces an Equity Buyback for 2,000,000 shares, representing 3.08% for ¥8,000 million.	Feb. 08	CI
Kaneka Corporation authorizes a Buyback Plan.	Feb. 07	CI
Kaneka Acquires Japan Medical Device Technology	Dec. 06	BU
Kaneka Corporation acquired Japan Medical Device Technology Co., Ltd.	Nov. 29	CI
Kaneka : Acquires Japan Medical Device Technology	Nov. 29	PU
Kaneka : Quarterly Financial Results for the 2nd Quarter, Ended September 30, 2023	Nov. 14	PU
Ex-dividend day for interim dividend	23-09-27	FA
Kaneka : initiates Clinical Trial for Acute Spinal Cord Injury using Human (Allogeneic) Amnion-derived Mesenchymal Stem Cells	23-08-29	PU
Kaneka : Quarterly Financial Results for the 1st Quarter, Ended June 30, 2023	23-08-18	PU
Kaneka : Quarterly Financial Summary for the 1st Quarter, Ended June 30, 2023	23-08-18	PU
Kaneka : initiates Clinical Trial for Duchenne Muscular Dystrophy using Human (Allogeneic) Amnion-derived Mesenchymal Stem Cells	23-07-27	PU
Kaneka : Data Sheet 2022	23-07-20	PU
Kaneka : Financial Summary for the Fiscal Year Ended March 31, 2023	23-05-23	PU
Sun-Novo Pharma Gets License to Produce Kaneka’s Transdermal Patches	23-05-16	MT
Kaneka Corporation Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Kaneka Corporation

Equities

4118

JP3215800008

Summary

Filters